1,030
Participants
Start Date
July 31, 2001
Primary Completion Date
April 30, 2008
Study Completion Date
September 30, 2010
fluorouracil
Given IV
gemcitabine hydrochloride
Given IV
leucovorin calcium
Given IV
clinical observation
No intervention
Institute of Oncology at Prince of Wales Hospital, Randwick
Flinders Medical Centre, Bedford Park
Institute for Clinical and Experimental Medicine, Preha 4
Tampere University Hospital, Tampere
Policlinico Borgo Roma, Verona
Hopital Tenon, Paris
Cross Cancer Institute at University of Alberta, Edmonton
British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna
British Columbia Cancer Agency - Vancouver Island Centre, Victoria
CancerCare Manitoba, Winnipeg
Nova Scotia Cancer Centre, Halifax
Cancer Research Institute at Queen's University, Kingston
Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston
London Regional Cancer Program at London Health Sciences Centre, London
Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa
Edmond Odette Cancer Centre at Sunnybrook, Toronto
Princess Margaret Hospital, Toronto
St. Joseph's Health Centre - Toronto, Toronto
Hopital Charles Lemoyne, Greenfield Park
McGill Cancer Centre at McGill University, Montreal
Universitaets-Kinderklinik Heidelberg, Heidelberg
Agia Olga Hospital, Athens
Petz Aladar County Hospital, Gydr
Kyoto University Hospital, Kyoto
Uppsala University Hospital, Uppsala
Inselspital Bern, Bern
Royal Liverpool University Hospital, Liverpool
Collaborators (1)
NCIC Clinical Trials Group
NETWORK
Australasian Gastro-Intestinal Trials Group
NETWORK
Royal Liverpool University Hospital
OTHER_GOV